Blues progression: From a dye to a placebo to an Alzheimer’s treatment?
Monday, October 10, 2016 - 19:51
in Psychology & Sociology
Why are Alzheimer’s drug developers getting the blues? It depends on what’s meant by “getting the blues.” The field has been plagued by a succession of failures of one experimental drug after another, Stanford drug researcher Jay Rajadas, PhD, tells me, with promising effects shown in early clinical trials disappearing like mist in the morning in crucial large-scale […]